Back to results
US 2009/0156588 A1Published application
3,4-dihydro-benzo[e][1,3]oxazin-2-ones
AssigneeNovartis AG
InventorsAndreas Billich, Hubert Gstach, Philipp Lehr
Life of this patent
Estimating the term…
Abstract
The present invention relates 3,4-dihydro-benzo[e][1,3]oxazin-2-ones which are substituted at the nitrogen atom by unsubstituted or substituted (C1-8)alkyl, (C3-8)cycloalkyl, (C3-8)cycloalkyl(C1-4)alkyl, (C6-18)aryl or (C6-18)aryl(C1-4)alkyl and their use as pharmaceuticals.
Claims11
A compound of formula
- wherein
- R is hydrogen, hydroxy or OR2,
- R1 is unsubstituted or substituted
- (C1-8)alkyl,
- (C3-8)cycloalkyl,
- (C3-8)cycloalkyl(C1-4)alkyl,
- (C6-18)aryl,
- (C6-18)aryl(C1-4)alkyl,
- wherein (C6-18)aryl is optionally annelated with another ring (system), and
- R2 is (C1-4)alkyl, halo(C1-4)alkyl, (C6-18)aryl(C1-4)alkyl or NH2SO2.
7 more elements
(canceled)
Dependencies are inferred from the claim text.